Ben Fulton
Impact in
-
- Glioma Diagnosis and Treatment
-
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
Papers in
-
- Prostate Cancer Treatment and Research 1
- Lung Cancer Treatments and Mutations 1
- Prostate Cancer Diagnosis and Treatment 1
- Electrolyte and hormonal disorders 1
- Surgery 2
- Esophageal Cancer Research and Treatment 1
- Co-authors
- Sarah Jefferies (1 shared paper)Anthony J. Chalmers (1 shared paper)Susan Short (1 shared paper)Allan James (1 shared paper)Catherine McBain (1 shared paper)Caroline Kelly (1 shared paper)Jon Stobo (1 shared paper)Simon J. Crabb (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Technical Innovations & Patient Support in Radiation Oncology (1 paper)Trials (1 paper)Clinical and Translational Radiation Oncology (1 paper)PubMed (2 papers)
- Partner nations
- United KingdomBelgiumUnited States
In The Last Decade
Ben Fulton
7 papers receiving 74 citations
Peers
Comparison fields: 5 of 29
- Genetics 26
- Oncology 40
- Health Informatics 1
- Cancer Research 10
- Molecular Biology 34
Countries citing papers authored by Ben Fulton
This map shows the geographic impact of Ben Fulton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Fulton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Fulton more than expected).
Fields of papers citing papers by Ben Fulton
This network shows the impact of papers produced by Ben Fulton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Fulton. The network helps show where Ben Fulton may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben Fulton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 49 | |
| 2 | 2020 | 7 | |
| 3 | 2017 | 6 | |
| 4 | 2024 | 6 | |
| 5 | 2017 | 3 | |
| 6 | 2016 | 2 | |
| 7 | Alternate day steroids in renal transplant patients. | 1977 | 1 |
About Ben Fulton
Ben Fulton is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Genetics, Oncology and Obstetrics and Gynecology, having authored 7 papers that have together received 74 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (1 paper), PARP inhibition in cancer therapy (1 paper), Prostate Cancer Treatment and Research (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Lung Cancer Treatments and Mutations (1 paper), Prostate Cancer Diagnosis and Treatment (1 paper), Esophageal Cancer Research and Treatment (1 paper) and Electrolyte and hormonal disorders (1 paper). The work is most often cited by research in Genetics (26 citations), Oncology (40 citations), Health Informatics (1 citation), Cancer Research (10 citations) and Molecular Biology (34 citations). Ben Fulton has collaborated with scholars based in United Kingdom, Belgium and United States. Frequent co-authors include Sarah Jefferies, Anthony J. Chalmers, Susan Short, Allan James, Catherine McBain, Caroline Kelly, Jon Stobo, Simon J. Crabb, Alison Birtle and Robert J. Jones. Their work appears in journals such as Annals of Oncology, Technical Innovations & Patient Support in Radiation Oncology, Trials, Clinical and Translational Radiation Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.